期刊文献+

雌激素、运动与绝经后骨质疏松研究现状 被引量:3

原文传递
导出
摘要 随着社会的老龄化,骨质疏松的患病率也在逐年增加,主要发生在中老年人,尤其是绝经后妇女。普遍认为,绝经导致的雌激素水平下降,骨形成和骨吸收失衡,是绝经后骨质疏松发生的主要原因。因此,雌激素替代疗法对绝经后骨质疏松具有明显的预防和治疗作用,而运动作为一种新型的骨质疏松康复手段,越来越受到人们的关注。本文就雌激素、运动与绝经后骨质疏松进行综述。
作者 杨明
机构地区 杭州师范大学
出处 《中国运动医学杂志》 CAS CSCD 北大核心 2009年第4期478-481,共4页 Chinese Journal of Sports Medicine
  • 相关文献

参考文献51

  • 1Lozo P,Krpan D,Krvavica A,et al.Bone histology in postmenopausal osteoporosis-variations in cellular activity.Acta Med Croatica,2004,58(1):5-11.
  • 2Zallone A.Direct and indirect estrogen actions on osteoblasts and osteoclasts.Ann N Y Acad Sci,2006,1068:173-179.
  • 3Komm BS,Terpening CM,Benz DJ,et al.Estrogen binding,receptor mRNA,and biologic response in usteoblast-like osteosarcoma cells.Science,1988,241 (4861):81-84.
  • 4Pensler JM,Radosevich JA,Higbee R,et al.Ostenclasts isolated from membranous bone in children exhibit nuclear estrogen and progesterone receptors.J Bone Miner Res,1990,5 (8):797-802.
  • 5Sims NA,Clement-Lacroix P,Miner D,et al.A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice.J Clin Invest,2003,111 (9):1319-1327.
  • 6Yamaguchi M and Weitzmann MN.The estrogen 17beta-estradiol and phytoestrogen genistein mediate differential effects on osteoblastic NF-kappaB activity.Int J Mol Med,2009,23 (2):297-301.
  • 7Ogita M,Rached MT,Dworakowski E,et al.Differentiation and proliferation of periosteal osteoblast progenitors are differentially regulated by estrogens and intermittent parathyroid hormone administration.En docrinology,2008,149(11):5713-5723.
  • 8Liang L,Yu JF,Wang Y,et al.Estrogen regulates expression of osteoprotegerin and RANKL in human periodontal ligament cells through estrogen receptor beta.J Periodontol,2008,79(9):1745-1751.
  • 9Bord S,Ireland DC,Beavan SR,etal.The effects of estrogen on osteoprotegerin,RANKL,and estrogen receptor expression in human osteoblasts.Bone,2003,32(2):136-141.
  • 10Vega D,Maalouf NM and Sakhaee K.The role of receptor activator of nuclear factur-kappaB (RANK)/RANK ligand/osteoprotegerin:clinical implications.J Clin Endocrinol Metab,2007,92 (12):4514-4521.

二级参考文献126

共引文献199

同被引文献32

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部